Inventor · disambiguated record
Andreas Reik
Also filed as: REIK ANDREAS
22 granted patents·8 pending applications·408 citations·filing 2007–2022
96Inventor score
Files withSANGAMO THERAPEUTICS INC13SANGAMO BIOSCIENCES INC10CHILDRENS MEDICAL CENTER2BIOGEN1BIOVERATIV THERAPEUTICS INC1
Top patents by PatentIndex Score
30 records- 0198US9902974B2Methods and compositions for treatment of a genetic conditionSANGAMO BIOSCIENCES INC·Filed 2015·Granted Feb 27, 2018·29 cites·7 claims
- 0298US9873894B2Methods and compositions for treatment of a genetic conditionSANGAMO BIOSCIENCES INC·Filed 2014·Granted Jan 23, 2018·86 cites·19 claims
- 0398US8945868B2Methods and compositions for modification of a HLA locusCOLLINGWOOD TREVOR·Filed 2011·Granted Feb 3, 2015·122 cites·9 claims
- 0497US8563314B2Methods and compositions for modulating PD1GREGORY PHILIP D·Filed 2010·Granted Oct 22, 2013·86 cites·41 claims
- 0596US10196651B2Methods and compositions for treatment of a genetic conditionSANGAMO THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·16 cites·17 claims
- 0695US10196652B2Methods and compositions for treatment of a genetic conditionSANGAMO THERAPEUTICS INC·Filed 2018·Granted Feb 5, 2019·11 cites·21 claims
- 0793US10072062B2Methods and compositions for modification of a HLA locusSANGAMO BIOSCIENCES INC·Filed 2015·Granted Sep 11, 2018·11 cites·11 claims
- 0893US10046028B2Methods and compositions for modulating PD1SANGAMO BIOSCIENCES INC·Filed 2016·Granted Aug 14, 2018·7 cites·3 claims
- 0988US9957501B2Nuclease-mediated regulation of gene expressionSANGAMO BIOSCIENCES INC·Filed 2016·Granted May 1, 2018·6 cites·13 claims
- 1087US10808020B2Nuclease-mediated regulation of gene expressionSANGAMO THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·6 cites·25 claims
- 1186US11021696B2Nuclease-mediated regulation of gene expressionCHILDRENS MEDICAL CENTER·Filed 2014·Granted Jun 1, 2021·4 cites·6 claims
- 1286US10907175B2Isolated human cell with an inactivated glucocorticoid receptor geneSANGAMO BIOSCIENCES INC·Filed 2015·Granted Feb 2, 2021·2 cites·7 claims
- 1385US10619154B2Nuclease-mediated regulation of gene expressionSANGAMO THERAPEUTICS INC·Filed 2018·Granted Apr 14, 2020·3 cites·12 claims
- 1485US10072066B2Methods and compositions for treatment of a beta thalessemiaSANGAMO BIOSCIENCES INC·Filed 2015·Granted Sep 11, 2018·6 cites·12 claims
- 1584US10858416B2Methods and compositions for modification of a HLA locusSANGAMO THERAPEUTICS INC·Filed 2018·Granted Dec 8, 2020·1 cites·9 claims
- 1683US9650648B2Methods and compositions for treatment of a genetic conditionSANGAMO BIOSCIENCES INC·Filed 2013·Granted May 16, 2017·4 cites·11 claims
- 1782US11235026B2Methods and compositions for modulating PD1SANGAMO THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·1 cites·7 claims
- 1881US2023416775A1Methods and compositions for treatment of a genetic conditionSANGAMO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1980US9963715B2Methods and compositions for treatment of a genetic conditionSANGAMO BIOSCIENCES INC·Filed 2013·Granted May 8, 2018·3 cites·11 claims
- 2079US9402879B2Methods and compositions for modulating PD1SANGAMO BIOSCIENCES INC·Filed 2013·Granted Aug 2, 2016·2 cites·7 claims
- 2172US9217026B2Method of inactivating a glucocorticoid receptor gene in an isolated cellREIK ANDREAS·Filed 2007·Granted Dec 22, 2015·2 cites·1 claims
- 2270US11884930B2Method of inactivating a glucocorticoid receptor gene in an isolated cellSANGAMO THERAPEUTICS INC·Filed 2020·Granted Jan 30, 2024·0 cites·12 claims
- 2370US2021054046A1Methods and compositions for modification of a hla locusSANGAMO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2468US11492643B2Methods and compositions for treatment of a genetic conditionSANGAMO THERAPEUTICS INC·Filed 2018·Granted Nov 8, 2022·0 cites·6 claims
- 2566US2021348143A1Nuclease-mediated regulation of gene expressionCHILDRENS MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 2665US2022395556A1Methods and compositions for modulating pd1SANGAMO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2761US2024301375A1Ciita targeting zinc finger nucleasesSANGAMO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2859US2021024606A1Nuclease-mediated regulation of gene expressionSANGAMO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2959US2020318140A1Methods and compositions for increasing rna activity in a cellBIOVERATIV THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3051US2017137845A1Methods and compositions for increasing rna activity in a cellBIOGEN·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Reik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →